Non-small-lung-cell Cancer, NSCLC
1 clinical trials · Condition
◉ Watch Non-small-lung-cell Cancer, NSCLC
| Record | Firm | Date |
|---|---|---|
| A Study With Pembrolizumab for Non-small Cell Lung Cancer (NSCLC) (NCT04393883) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2021-04-01 |
Track Non-small-lung-cell Cancer, NSCLC automatically
Every clearance here is in the API, with alerts when new ones post.